Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
908.10
-8.15 (-0.89%) Natco Pharma informs about press release
Date: 03-05-2021Natco Pharma has informed that it has enclosed the Press Release on May 3rd 2021, titled ‘NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19 treatment’.
The above information is a part of company’s filings submitted to BSE.